(Q40821790)

24 September 2017

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease (English)

1 reference

24 September 2017

0 references

0 references

Su Z

1

1 reference

24 September 2017

Peluso MV

2

1 reference

24 September 2017

Raffegerst SH

3

1 reference

24 September 2017

Schendel DJ

4

1 reference

24 September 2017

Roskrow MA

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

European Journal of Immunology

24 September 2017

1 reference

24 September 2017

31

1 reference

24 September 2017

947-958

1 reference

24 September 2017

3

1 reference

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Antigen recognition by class I-restricted T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Major histocompatibility complex class I-restricted cytotoxic T lymphocyte responses to Epstein-Barr virus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Expression of epstein-barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-4141%28200103%2931%3A3%3C947%3A%3AAID-IMMU947%3E3.0.CO%3B2-M

10.1002/1521-4141(200103)31:3<947::AID-IMMU947>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference